Align Technology, Inc. (ALGN)
$
138.43
+6.52 (4.71%)
Key metrics
Financial statements
Free cash flow per share
8.7481
Market cap
10 Billion
Price to sales ratio
2.5195
Debt to equity
0.0221
Current ratio
1.2887
Income quality
6.3206
Average inventory
236 Million
ROE
0.0975
Technology
Technology – consumer electronics
Largecap
With a market cap of 121,78 bil stock is ranked 1
Low risk
ISS score of this stock is ranked 1
Company description
Profile
Align Technology, Inc. is a prominent medical device company known for designing, manufacturing, and marketing Invisalign clear aligners and iTero intraoral scanners, along with related services tailored for orthodontists, general practitioner dentists, and professionals involved in restorative and aesthetic dentistry. The company earned an interest income of $20,218,000.00 showcasing its financial investments. Additionally, it incurred an income tax expense of $187,597,000.00 indicating its tax obligations. With an operating income ratio of 0.15 the firm demonstrates its operational profitability margins. The gross profit stands at $2,799,159,000.00 highlighting the company's profitability from core operations, while the weighted average number of diluted shares outstanding is 74,993,000.00 reflecting potential dilution effects. Operating through two main segments—the Clear Aligner segment, which provides a range of treatment options for teenagers and younger patients, and the Scanners and Services segment, which offers advanced scanning solutions—the company serves a wide market that includes the United States, Switzerland, China, and beyond. The stock is priced at $131.39 positioning it in the higher-end market, with an average trading volume of 1,492,498.00 indicating moderate liquidity. Holding a mid-range market capitalization of $10,034,287,922.00 Align Technology, Inc. is recognized as a steady performer in the medical technology field. It is a key player in the Medical - Devices industry, contributing significantly to the overall market landscape and driving innovation and growth within the Healthcare sector. The diverse product offerings and reliable financial performance underscore Align Technology’s pivotal role in shaping the future of orthodontic and dental treatment solutions.
Is Align Technology, Inc. (ALGN) a good investment?
Investing in Align Technology, Inc. (ALGN) depends on multiple factors, including revenue growth, profit margins, debt-to-equity ratio, earnings per share, and return on equity. Analysts have rated it as B+, with a Bullish outlook. Always conduct your own research before investing.
What is Align Technology, Inc. (ALGN)'s stock forecast?
Analysts predict Align Technology, Inc. stock to fluctuate between $122 (low) and $246.19 (high) in the next 365 days, reflecting market expectations and potential volatility.
What is Align Technology, Inc.'s market capitalization?
As of 2025-10-30, Align Technology, Inc.'s market cap is $10,034,287,922, based on 72,486,368 outstanding shares.
How does Align Technology, Inc. compare to competitors like Eli Lilly & Co.?
Compared to Eli Lilly & Co., Align Technology, Inc. has a Lower Market-Cap, indicating a difference in performance.
How can I buy Align Technology, Inc. (ALGN) stock?
To buy Align Technology, Inc. (ALGN) stock: Open a brokerage account (e.g., Robinhood, TD Ameritrade, E-Trade). Search for ALGN. Place an order (Market, Limit, etc.).
What is the best time to invest in Align Technology, Inc.?
The best time to invest depends on market trends and technical indicators, which show a Bullish trend based on economic conditions and company performance.
How did Align Technology, Inc. perform in the last earnings report?
Revenue: $3,999,012,000 | EPS: $5.63 | Growth: -3.26%.
Where can I find Align Technology, Inc.'s investor relations reports?
Visit https://www.aligntech.com/investor-relations for detailed financial reports.
Where can I find historical stock prices for Align Technology, Inc.?
You can explore historical data from here
What is the all-time high and low for Align Technology, Inc. stock?
All-time high: $737.45 (2021-09-23) | All-time low: $122 (2025-09-25).
What are the key trends affecting Align Technology, Inc. stock?
Key trends include market demand, economic conditions, interest rates, and industry competition, which influence the stock's performance.
News
zacks.com
Align Technology jumps 15% after Q3 earnings and revenues beat estimates, though steep margin declines weigh on results.
fool.com
Align stock beat on sales and beat on earnings. Foreign exchange rates alone suffice to explain most of Align's gains.
seekingalpha.com
Align Technology, Inc. ( ALGN ) Q3 2025 Earnings Call October 29, 2025 4:30 PM EDT Company Participants Shirley Stacy - Vice President of Corporate Communications & Investor Relations Joseph Hogan - President, CEO & Director John Morici - CFO & Executive VP of Global Finance Conference Call Participants Elizabeth Anderson - Evercore ISI Institutional Equities, Research Division Jonathan Block - Stifel, Nicolaus & Company, Incorporated, Research Division Michael Cherny - Leerink Partners LLC, Research Division Jeffrey Johnson - Robert W. Baird & Co. Incorporated, Research Division Brandon Vazquez - William Blair & Company L.L.C.
zacks.com
The headline numbers for Align Technology (ALGN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zacks.com
Align Technology (ALGN) came out with quarterly earnings of $2.61 per share, beating the Zacks Consensus Estimate of $2.37 per share. This compares to earnings of $2.35 per share a year ago.
prnewswire.com
NEW YORK , Oct. 18, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
prnewswire.com
NEW YORK , Oct. 13, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
prnewswire.com
NEW YORK , Oct. 8, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Align Technology, Inc. ("Align" or the "Company") (NASDAQ: ALGN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
globenewswire.com
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Align (ALGN) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Align and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
seekingalpha.com
Align Technology is rated a hold due to deteriorating fundamentals, declining revenue growth, and eroding competitive advantages post-COVID-19. ALGN faces margin pressure from increased competition, ineffective patent protection, and a shift toward cheaper, direct-to-consumer clear aligner alternatives. Valuation models suggest limited upside, with intrinsic value estimates below current levels unless management can restore growth or strengthen the company's moat.
See all news
